• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SILK ROAD MEDICAL ENROUTE TRANSCAROTID STENT; STENT, CAROTID

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SILK ROAD MEDICAL ENROUTE TRANSCAROTID STENT; STENT, CAROTID Back to Search Results
Model Number FG11815
Medical Device Problem Code Adverse Event Without Identified Device or Use Problem (2993)
Health Effect - Clinical Codes High Blood Pressure/ Hypertension (1908); Low Blood Pressure/ Hypotension (1914); Muscle Weakness/Atrophy (1967); Dysphasia (2195); Ischemia Stroke (4418); Thrombosis/Thrombus (4440); Facial Paralysis (4585)
Date of Event 03/25/2026
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Detailed product information was not provided to bsc.We completed a good faith effort to obtain the information.Because the product lot number is unknown at this time, we are unable to provide the complete unique identifier (udi) # and other specific product information.If additional details become available, a supplemental report will be submitted.
 
Event or Problem Description
It was reported that the patient experienced stent thrombosis.An enroute transcarotid stent was selected for use in a right side transcarotid artery revascularization (tcar) procedure.The patient exhibited labile blood pressure during the procedure, ranging from 200mmhg to below 100mmhg.The procedure was completed with no other issues.Twenty-eight hours after the procedure, the patient experienced left side weakness, slurred speech and facial droop.Imaging performed reveled stent thrombosis.The patient is scheduled to transition to rehabilitation.
 
Event or Problem Description
It was reported that the patient experienced stent thrombosis.An enroute transcarotid stent was selected for use in a right side transcarotid artery revascularization (tcar) procedure.The patient exhibited labile blood pressure during the procedure, ranging from 200mmhg to below 100mmhg.The procedure was completed with no other issues.Twenty-eight hours after the procedure, the patient experienced left side weakness, slurred speech and facial droop.Imaging performed reveled stent thrombosis.The patient is scheduled to transition to rehabilitation.
 
Additional Manufacturer Narrative
Detailed product information was not provided to bsc.We completed a good faith effort to obtain the information.Because the product lot number is unknown at this time, we are unable to provide the complete unique identifier (udi) # and other specific product information.If additional details become available, a supplemental report will be submitted.Investigation results: ship history review: a ship history review for the reported upn was performed for the reporting customer.Batch 18433825 was most recently shipped to the reporting facility in the 3-year period preceding the procedure date.There were no manufacturing deviations for this batch number that could have contributed to the reported event.Device history record (dhr) review: it was confirmed this device met manufacturing specification prior to distribution and there were no manufacturing deviations which could have contributed to the reported event.Labeling review: review of the instructions for use (ifu) confirmed there was relevant content and sufficient guidance with respect to the circumstances described within this complaint.No updates are required to the ifu as a result of this event.Risk review: a review of the enroute transcarotid stent device confirmed that the reported event is a known event defined in the product's risk management documentation.This event type has been accounted for during product risk analysis to support acceptable risk benefit for the product.Investigation conclusion: based on a thorough review of the reported complaint, boston scientific has assigned an investigation conclusion code of known inherent risk of device.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ENROUTE TRANSCAROTID STENT
Common Device Name
STENT, CAROTID
Manufacturer (Section D)
SILK ROAD MEDICAL
1213 innsbruck drive
sunnyvale CA 94089
Manufacturer (Section G)
SILK ROAD MEDICAL INC.
27th ave north plymouth
minneapolis MN 55447
Manufacturer Contact
mark mischke
4100 hamline ave n
arden hills, MN 55112
7634941632
MDR Report Key24954770
Report Number2124215-2026-21728
Device Sequence Number5406223
Product Code NIM
UDI-Device Identifier00811311021277
UDI-Public(01)00811311021277
Combination Product (Y/N)N
Initial Reporter StateOH
Initial Reporter CountryUS
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2026
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 07/01/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Model NumberFG11815
Device Catalogue NumberFG11815
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 03/25/2026
Supplement Date Received by Manufacturer06/03/2026
Initial Report FDA Received Date04/22/2026
Supplement Report FDA Received Date07/01/2026
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
Patient Age85 YR
Patient SexMale
Patient RaceWhite
-
-